Report on Research Compliance
Please click here for full article
Please click here for full article
“Nothing is more fundamental to the ethical conduct of clinical trials than the informed consent of research participants. The Nuremberg Code and every subsequent major international statement about ethics and medical research enshrine this role.” In his recent article in Science and Engineering Ethics, Dr. Mark Yarborough, Dean’s Professor of…
Since 2006, the results of a multi-site clinical trial (MIST) that tested a surgical device have been at the center of dispute among cardiologists on both sides of the Atlantic.
Millions of people around the world participate in research trials each year, whether for personal, financial or humanitarian reasons. They submit their DNA, organs, body chemistry or personal history to studies that aim to better society. A substantive investigative news report by San Diego’s independent investigative news source, Inewsource.org by…
A Boston Globe report (below) focuses on three recent reports in the Journal of the American Medical Association (JAMA) by Harvard researchers who violated the journal’s disclosure policy by failing to disclose their financial ties to companies that had the most to gain from their purported findings.
The decision to suspend the trial is viewed as highly questionable, raising disturbing questions about the role that marketing played–especially in light of the fact that Zytiga’s patent is due to expire in 2017.
Following on the heels of an investigative report by David Armstrong of The Wall Street Journal <https://ahrp.stagenoises.ch/cms/content/view/286/27/> the Associated Press reports that JAMA claims it was misled.